ELMD vs. NNOX, ZJYL, TMCI, AXGN, SGHT, TCMD, LUNG, SMTI, RCEL, and DCTH
Should you be buying Electromed stock or one of its competitors? The main competitors of Electromed include Nano-X Imaging (NNOX), Jin Medical International (ZJYL), Treace Medical Concepts (TMCI), AxoGen (AXGN), Sight Sciences (SGHT), Tactile Systems Technology (TCMD), Pulmonx (LUNG), Sanara MedTech (SMTI), AVITA Medical (RCEL), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry.
Nano-X Imaging (NASDAQ:NNOX) and Electromed (NYSE:ELMD) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk.
Electromed has a net margin of 8.14% compared to Electromed's net margin of -611.89%. Nano-X Imaging's return on equity of 10.97% beat Electromed's return on equity.
Nano-X Imaging currently has a consensus target price of $16.25, indicating a potential upside of 89.17%. Given Electromed's higher possible upside, research analysts clearly believe Nano-X Imaging is more favorable than Electromed.
Nano-X Imaging has a beta of 2.04, suggesting that its stock price is 104% more volatile than the S&P 500. Comparatively, Electromed has a beta of 0.25, suggesting that its stock price is 75% less volatile than the S&P 500.
In the previous week, Nano-X Imaging had 2 more articles in the media than Electromed. MarketBeat recorded 2 mentions for Nano-X Imaging and 0 mentions for Electromed. Electromed's average media sentiment score of 0.62 beat Nano-X Imaging's score of 0.00 indicating that Nano-X Imaging is being referred to more favorably in the media.
Nano-X Imaging received 13 more outperform votes than Electromed when rated by MarketBeat users. However, 86.67% of users gave Electromed an outperform vote while only 68.42% of users gave Nano-X Imaging an outperform vote.
21.5% of Nano-X Imaging shares are held by institutional investors. Comparatively, 40.8% of Electromed shares are held by institutional investors. 7.7% of Nano-X Imaging shares are held by company insiders. Comparatively, 12.7% of Electromed shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Electromed has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.
Summary
Electromed beats Nano-X Imaging on 10 of the 17 factors compared between the two stocks.
Get Electromed News Delivered to You Automatically
Sign up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ELMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Electromed Competitors List
Related Companies and Tools
